An erythrocyte-delivered photoactivatable oxaliplatin nanoprodrug for enhanced antitumor efficacy and immune response

The outcome of conventional platinum (Pt)-based chemotherapy is limited by reduced circulation, failure to accumulate in the tumor, and dose-limiting toxicity arising from non-controllable activation. To address these limitations, we present an erythrocyte-delivered and near-infrared (NIR) photoacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Deng, Zhiqin, Zhu, Qi, Zhao, Jianxiong, Xie, Kai, Shi, Peng, Wang, Zhigang, Chen, Xianfeng, Wang, Feng, Shi, Jiahai, Zhu, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580000/
https://www.ncbi.nlm.nih.gov/pubmed/34880985
http://dx.doi.org/10.1039/d1sc02941j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580000/
https://www.ncbi.nlm.nih.gov/pubmed/34880985
http://dx.doi.org/10.1039/d1sc02941j

Ejemplares similares